This post used to be a comparison of the common cold, seasonal flu and H1N1 swine flu. That framing is fifteen years out of date, and keeping it would be misleading in a specific way: H1N1 is no longer a separate thing to tell apart from seasonal flu. The 2009 pandemic strain settled into circulation as one of the ordinary seasonal influenza A subtypes, A(H1N1)pdm09. When you get influenza A now, that is frequently what it is.

The four illnesses actually worth separating in 2026 are cold, influenza, COVID-19 and RSV.

The honest answer first

You cannot reliably tell them apart from symptoms. Neither can I, over video, and neither can anyone in an exam room with a stethoscope and a light and all the time in the world, which is worth saying plainly because patients arrive having read a symptom chart and expecting me to run their answers through it and hand back a name.

That is not a limitation of describing symptoms carefully. All four are respiratory viruses that produce overlapping illness, and the overlap became worse rather than better once COVID stopped presenting the way it did in 2020. Loss of smell was a useful discriminator for about a year and then largely stopped being one.

So everything below is about probabilities and about what changes your management, not about a checklist that gives you an answer.

What each one tends to look like

A cold builds. Over a day or two, it goes sore throat, then congestion and runny nose, then cough. Fever is uncommon in adults. You feel unwell and you keep functioning.

Influenza arrives. People remember the hour. Fever, headache, aching muscles, exhaustion out of proportion to the respiratory symptoms, dry cough. The abruptness is the most useful single feature, and it is still only suggestive.

COVID-19 in 2026 mostly looks like a bad cold with more fatigue and a more persistent cough, often with a sore throat that patients describe as worse than the rest of it. Onset is usually less abrupt than flu.

RSV in adults gets missed constantly because everyone files it under a childhood illness. In an older adult or someone with COPD or heart failure it presents as wheeze, worsening breathlessness and a cough that will not clear, frequently without much fever. If a patient over 65 with lung disease has been coughing and wheezing for a week, RSV belongs on the list.

Why testing is worth it now, when it was not in 2011

The old advice was that testing rarely changed anything. That was fair when the treatments were marginal.

It is no longer fair, for one reason: there are time-limited treatments, and the clock starts at symptom onset.

Oseltamivir works best started within 48 hours (1). Baloxavir is a single dose, and the trial that established it in adults and adolescents also enrolled within 48 hours of symptom onset (2). For COVID, nirmatrelvir and ritonavir is a five-day window from symptom onset in people at higher risk. Miss the window and the conversation becomes supportive care.

Combination home tests that read out COVID and influenza A and B from a single swab are now available over the counter. They are less sensitive than what a lab runs, particularly early, and a negative on day one in someone who clearly has influenza is a false negative more often than it is reassurance. A positive is useful. A negative in a sick person is not an all-clear.

The practical consequence: if you are in a group where antivirals are worth having, test early rather than waiting to see how it goes. Waiting is what closes the window.

What I do with this over video

I ask when it started, and I ask for the hour rather than the day, because abrupt onset is the most discriminating piece of history available and people can usually place it.

I ask what the household has. In a season, the household is often better evidence than the symptoms.

I ask about breathing rather than about cough, because cough is universal and shortness of breath is what separates the people who need to be seen. Anyone reporting new breathlessness at rest, chest pain, confusion, or an inability to keep fluids down gets routed out of the video visit, and my order of preference is primary care first, urgent care next, emergency department when it needs to be. Primary care is the hardest of the three to get into quickly, which is exactly the problem.

On the vaccines

All four illnesses here have a prevention story, and three of them have vaccines. I am deliberately not listing eligibility ages in this post, because the authoritative source for those is the CDC schedule and I will not publish vaccine ages under my license on the strength of a secondary source. Ask your pharmacist or your physician, and see my separate post on this season’s COVID vaccine for the version of that conversation I can source properly.

For patients

If it hit you all at once and you feel like you were run over, think influenza and test today rather than tomorrow, because the treatment window is 48 hours.

If it built up gradually and mostly involves your nose and throat, it is probably a cold and there is nothing to take for it.

If you are older or have lung disease and you have been wheezing for a week without much fever, ask specifically about RSV.

A negative home test on the first day means very little. Call about breathing, not about cough.

For colleagues

Adult RSV is the one being missed. It gets called a COPD exacerbation or an atypical pneumonia and never gets tested for, and the epidemiology suggests it is a good deal more common in older adults than our diagnosis rate implies.

Antiviral time windows deserve to be said out loud to patients before they are sick, particularly in the higher-risk groups. Patients who know there is a clock behave differently in the first 24 hours.

The Bottom Line

H1N1 is not a separate illness any more, it is one of the ordinary seasonal influenza A subtypes, and that is why this post needed rewriting. Cold, flu, COVID and RSV cannot be reliably separated by symptoms, and the abruptness of onset is the only feature that carries much weight. What has genuinely changed since 2011 is that testing now changes management, because oseltamivir and baloxavir want to be started within 48 hours and the COVID antiviral within five days. If you are going to test, test early. Waiting is the mistake.

Related Reading

Do I Have the Flu? Common Influenza Symptoms Explained

2026-2027 COVID Vaccine: Who Qualifies, and Do You Need a Doctor’s Note?

Flu Prevention: Vaccines, Symptoms, and Treatment Options

Why Won’t Antibiotics Cure a Viral Infection? Doctor Explains

Scott Rennie, D.O.
Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.

Sources

1. Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis. 2019;68(6):e1-e47. PMID 30566567. https://pubmed.ncbi.nlm.nih.gov/30566567/

2. Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 2018;379(10):913-923. PMID 30184455. https://pubmed.ncbi.nlm.nih.gov/30184455/

3. World Health Organization. Influenza (seasonal) fact sheet. https://www.who.int/news-room/fact-sheets/detail/influenza-%28seasonal%29